Co-Diagnostics

$9.77
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.23 (+2.41%) As of 4:33 PM UTC today

Why Robinhood?

You can buy or sell Co-Diagnostics and other stocks, options, and ETFs commission-free!

About CODX

Co-Diagnostics, Inc. engages in the development and innovation of molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications. Its diagnostics systems enable very rapid, low-cost, molecular testing for organisms and genetic diseases by automating historically complex procedures in both the development and administration of tests.

CEO

Dwight Howard Egan

Employees

Headquarters

Salt Lake City, Utah

Founded

2013

Market Cap

296.31M

Price-Earnings Ratio

5.79

Dividend Yield

—

Average Volume

1.47M

High Today

$9.87

Low Today

$9.37

Open Price

$9.38

Volume

413.07K

52 Week High

$30.99

52 Week Low

$7.86

CODX Earnings

-$0.10

$0.14

$0.39

$0.63

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Estimated

— per share

Actual

Expected May 13, After Hours